Intervencni a Akutni Kardiologie最新文献

{"title":"Problems of care for STEMI patients in coronavirus pandemic","authors":"S. Simek","doi":"10.36290/KAR.2021.027","DOIUrl":"https://doi.org/10.36290/KAR.2021.027","url":null,"abstract":"The covid-19 pandemic negatively affects time-dependent care and the course of STEMI in several aspects: Some patients delay seeking emergency care or even do not call it at all because of fear of contracting covid-19 at hospitals. The presentations of STEMI and covid-19 can overlap and mimic each other. Both conditions may coexist. Uncertainty regarding diagnosis may add to delays. Provider΄s concerns about the covid-19 infection or lack of cath lab staff may lead to changes in treatment algorhithms. There may also be delay due to the infection-control measures employed by medical staff. Reduction in non-covid care, overwhelmed emergency medical services and hospitals, staff-absences, and lack of beds may all lead to treatment delay or even inability to provide it. Inflammatory and prothrombotic states in patients with covid-19 increase the risk of developing STEMI as well as that of STEMI complications. Hypoxia due to covid-19 lung disease deepens myocardial ischemia during STEMI and may extend the volume of STEMI and increase the risk of heart failure. Covid myocarditis Conclusion: It is apparent that STEMI in covid-19 infected patients is not the same disease process as STEMI that without covid-19 infection. Patients with STEMI and covid-19 have a higher risk of heart failure, cardiac arrest, cardiogenic shock, greater intracoronary thrombosis and stent thrombosis, resulting in higher cardiac and non-cardiac mortality. Aggressive antithrombotic treatment is recommended. Even in the covid era it is essential to insist on timely treatment of STEMI. Training of cardiac catheterization personnel on how to use personal protective equipment as well as vaccination are crucial to limit the risk of acquiring infection. (English) [ABSTRACT FROM AUTHOR] Infekce covid-19 a covidova pandemie představuji problem pro peci o nemocne se STEMI. Výskyt, průběh, lecbu a prognozu STEMI ovlivňuje covidova epidemie v několika aspektech: „ Cast nemocných z obavy před covidovou nakazou v nemocnici oddaluje přivolani zdravotnicke pomoci, nebo dokonce pomoc vůbec nezavola. Přiznaky STEMI a covid-19 se mohou překrývat a vzajemně napodobovat, navic mohou koexistovat, nejistota při stanoveni diagnozy může vest ke zpožděni lecby. Obava z covidove nakazy zdravotniků nebo nedostatek personalu katetrizacnich laboratoři může vest ke změně lecebných algoritmů. Přetižene zdravotni služby, omezeni „necovidove“ pece, chybějici personal, nedostatek lůžek mohou mit za nasledek prodlevu v lecbě STEMI až nemožnost lecbu poskytnout. Použiti ochranných prostředků proti siřeni covid-19 může vest ke zpožděni lecby. Zanětlivý a protrombotický stav během covidove infekce zvysuje riziko vzniku infarktu myokardu a zvysuje riziko trombotických komplikaci již probihajiciho STEMI. Hypoxie způsobena covidovým postiženim plic prohlubuje ischemii myokardu při AIM, může zvětsit rozsah infarktu a zvysuje riziko srdecniho selhani při AIM. Covidova myokarditida. Zavěr: STEMI u nemocneho s covid-19 neni","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What antithrombotic treatment is required in a patient after TAVI in the year 2021?","authors":"A. Širáková, P. Toušek, H. Linkova, V. Kocka","doi":"10.36290/kar.2021.001","DOIUrl":"https://doi.org/10.36290/kar.2021.001","url":null,"abstract":"","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Covid-19 and myocardial infarction","authors":"J. Dusek, J. Bis, J. Šťásek","doi":"10.36290/KAR.2021.025","DOIUrl":"https://doi.org/10.36290/KAR.2021.025","url":null,"abstract":"V průběhu onemocněni covid-19 (coronavirus disease 2019) způsobeneho virem SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) dochazi k vyssimu výskytu trombotických komplikaci, hlavně v oblasti žilniho systemu. Relativně caste je take postiženi kardiovaskularniho systemu, ktere se může manifestovat jako akutni infarkt myokardu, myokardiditida (s možným klinickým a EKG obrazem akutniho infarktu myokardu s ST elevacemi), stresova kardiomyopatie, koronarni spasmy nebo nespecificke myokardialni postiženi. V průběhu pandemie onemocněni covid-19 je casto pozorovan pokles incidence akutnich koronarnich syndromů. V lecbě akutniho infarktu myokardu zůstava metodou volby perkutanni koronarni angioplastika (PCI), ale zvl. v některých non PCI centrech je u pacientů s covid-19 a akutnim infarktem myokardu s elevacemi ST useků zvažovana trombolyticka terapie. Velký důraz je kladen na adekvatni ochranu zdravotnickeho personalu před nebezpecim nakazy onemocněnim covid-19.","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathogenesis of covid-19: principles of viral infection and immune response","authors":"J. Beneš, Dana Nováková","doi":"10.36290/KAR.2021.023","DOIUrl":"https://doi.org/10.36290/KAR.2021.023","url":null,"abstract":"Infekce způsobena SARS-CoV-2 může mit různe klinicke formy, od inaparentniho průběhu až po život-ohrožujici polyorganovou dysfunkci. Z hlediska patogeneze je možne tyto klinicke formy rozdělit na skupinu sliznicnich infekci (infekce dýchacich cest, gastroenteritida) a infekce vnitřnich organů (předevsim jde o pneumonii). Zvlastni problematiku představuje dysregulovana imunitni odpověď spojena s produkci prozanětlivých cytokinů (IL-1, IL-6, TNFα), ktera je jinak typicka pro zavažne bakterialni infekce. Znalost patogenetických souvislosti umožni lepe interpretovat výsledky virologických a serologických vysetřeni a pomaha při volbě individualizovane terapie covid-19.","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47436476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Overview of cardiovascular inolvement in patients with covid-19 infection","authors":"M. Radvan, M. Kamenik, L. Koc, Svatopluk Richter, Petr Kala","doi":"10.36290/KAR.2021.026","DOIUrl":"https://doi.org/10.36290/KAR.2021.026","url":null,"abstract":"Covid-19 je infekcni onemocněni způsobene virem SARS-CoV-2 (syndrom těžke respiracni tisně koronaviru 2). Celkova mortalita se pohybuje pod 0,5 %. Větsina umrti spada do věkove skupiny pacientů nad 60 let. Stejně devastujici může být tato infekce i pro mladsi pacienty s jiným těžkým chronickým onemocněnim. V akutnim stadiu covid-19 je vyssi riziko akutniho koronarniho syndromu, manifestace ci dekompenzace chronickeho srdecniho selhani, objevit se mohou i poruchy srdecniho rytmu, zanět srdecniho svalu ci perikardialni výpotek. Samostatnou kapitolu představuje zvýsene riziko vzniku trombembolie. Přime i nepřime postiženi myokardu je při těžsim průběhu běžne. Elevace troponinu je markerem horsi prognozy infekce SARS-CoV-2.","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiovascular complications and covid-19 infection","authors":"P. Pařízek","doi":"10.36290/KAR.2021.024","DOIUrl":"https://doi.org/10.36290/KAR.2021.024","url":null,"abstract":"Ackoliv infekce covid-19 dominantně postihuje respiracni system, je znamo, že může mit negativni vliv i na kardiovaskularni system. Cilem tohoto přehledu je uvedeni přicin a mechanismů kardiovaskularnich komplikaci způsobených koronavirem SARS-COV-2.","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Úspěšná sklerotizace perikardu bleomycinem u plicního adenokarcinomu s masivním recidivujícím perikardiálním výpotkem","authors":"Ivana Purnama Dewi, Ismail Damanik, Dita Aulia Rachmi, Kristin Purnama Dewi, Rochmad Romdoni","doi":"10.36290/kar.2021.004","DOIUrl":"https://doi.org/10.36290/kar.2021.004","url":null,"abstract":"","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49428368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mid-term results of percutaneous treatment of severe mitral regurgitation with MitraClip in patients with heart failure","authors":"Michaela Červinková, J. Hlavacek, P. Vojtíšek, M. Kvašňák, P. Červinka","doi":"10.36290/kar.2021.029","DOIUrl":"https://doi.org/10.36290/kar.2021.029","url":null,"abstract":"","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathology of covid-19","authors":"V. Stejskal, Ivo Šteiner, Monika Manethova","doi":"10.36290/KAR.2021.022","DOIUrl":"https://doi.org/10.36290/KAR.2021.022","url":null,"abstract":"Zakladnim patologickým projevem covid-19 je intersticialni pneumonie charakteru difuzniho alveolarniho poskozeni. Od DAD/ARDS z jiných přicin ma vsak několik zvlastnich histopatologických rysů: v plicnim parenchymu se casto nachazeji soucasně vsechna stadia DAD - akutni, subakutni i chronicke; ve vsech typech plicnich cev (mikrocirkulaci, tepnach i žilach) bývaji destickove a fibrinove tromby s tvorbou plicnich infarktů; zanět ma výraznou hemoragickou složku - prokrvaceni plic; jsou přitomny atypicke pneumocyty II. typu; v kapilarach se nachazeji zvlastni megakaryocyty; elektronmikroskopicky lze prokazat v buňkach viry; je výrazna tendence k bakterialni ci mykoticke superinfekci. V srdci jsou při covid-19 patologicke nalezy caste, zatim vsak nebyla prokazana žadna specificka reprodukovatelna histopatologie covid-19 myokardialniho poskozeni. Fatalni myokarditida je vzacna. Přicinou myokardialniho postiženi je nejspise toxický a kardiodepresorický vliv mediatorů zanětu, ktere jsou excesivně zvýsene při těžkem průběhu onemocněni.","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sirolimus-eluting balloon catheters","authors":"L. Pleva, Pavel Kukla","doi":"10.36290/kar.2020.046","DOIUrl":"https://doi.org/10.36290/kar.2020.046","url":null,"abstract":"Lékové drug-eluting balonkové katétry umožňují lokální aplikaci účinné antiproliferativní látky omezující neointimální hyperplazii do cévní stěny. Vzhledem ke snadné vazbě na povrch balonkového katétru a rychlému průniku do tkání bývá jako účinná látka využíván především paclitaxel. Sirolimové lékové balonkové katétry by však, obdobně jako sirolimové lékové stenty, mohly vykazovat vyšší účinnost oproti paclitaxelu. Klíčová slova: drug-eluting balonkové katétry, sirolimus, in-stent restenóza.","PeriodicalId":39081,"journal":{"name":"Intervencni a Akutni Kardiologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70138468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}